Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Sep 26, 2024 · GEN's Alex Philippidis ranked 50 institutions—universities, medical schools, research organizations, and teaching hospitals—according to how much NIH funding they had received.

Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% from the combined $963. ...

Dec 18, 2024 · The field of cell and gene therapy has seen a wave of exciting advances in the past 12 months. Following the landmark approval of the first CRISPR-based cell therapy in late 2023, investigators ...

Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...

Aug 23, 2024 · This year, GEN’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global community of around 18,000 ...

Sep 15, 2023 · GEN’s first-ever Top 10 A-List of contract developers and manufacturers is here. Of the top 10 companies listed, only three are headquartered in the U.S.; the rest are based in China, Germany ...

Jan 2, 2025 · Researchers from the Hubrecht Institute and their collaborators at other institutions have used a protein from zebrafish dubbed Hmga1 which plays a key role in heart regeneration, to reactivate ...

Oct 16, 2024 · Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology and several ...

Oct 28, 2024 · Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...